US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
MD

MDWD

$13.73
CONTROVERSY

Occupied territories Halal Trading Room controversy review flags companies domiciled in Israel under Occupied territories. as of 2026-09-11.

A public record of federal contracting, not a Sharia ruling and not our assessment of this company. It sits beside the verdict above and changes nothing about it.

Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-28
HTR non-permissible income <0.01%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.
Why this signal?
Structure3 of 5 timeframes bullish · 65.2% aligned
VWAPPrice holding above VWAP ($13.56)
VolumeRelative volume 5.4× the 20-day average
Momentum10-day rate of change +8.0%

MediWound Ltd. (MDWD) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Wall Street consensus
BUY
12 analysts
Price target
$29.83
+117.3% · 6 analysts
Institutional own.
56.0%
of shares
Momentum (10d)
+8.0%
rate of change
SMC grade
D · 44
65.2% aligned
NON-COMPLIANT
Sharia compliance
<0.01%
Non-permissible income — HTR, from filings (2025-12-31)
D · 44
SMC grade — 65.2% timeframe alignment
+8.0%
Rate of change (10d)
BUY
Wall Street consensus (12)
$29.83
Price target (+117.3%) · 6 analysts
56.0%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for MDWD — this runs off the critical path so the page paints first. It will appear here on its own.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2025-12-31. MDWD files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 0.00% 30.00% Pass
Interest-bearing investments 30.97% 30.00% Fail
Non-permissible income 0.00% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 0.00% 33.00% Pass
Interest-bearing investments 61.61% 33.00% Fail
Non-liquid assets 38.39% at least 20.00% Pass
Non-permissible income 0.00% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass
Cash + interest-bearing securities 61.61% 33.33% Fail
Non-permissible income 0.00% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass
Cash + interest-bearing securities 61.61% 33.33% Fail
Non-permissible income 0.00% 5.00% Pass

Dow Jones Islamic Market Unverified

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.00% 33.00% Pass
Cash + interest-bearing securities 28.10% 33.00% Pass
Non-permissible income 0.00% 5.00% Pass

S&P Shariah Unverified

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.00% 33.00% Pass
Cash + interest-bearing securities 32.08% 49.00% Pass
Non-permissible income 0.00% 5.00% Pass

MSCI M-Series Unverified

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass
Cash + interest-bearing securities 32.08% 33.33% Pass
Non-permissible income 0.00% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

19.6917.9216.1514.3812.612025-09-112026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
13.02
S2
13.20
S1
13.46
PIVOT
13.64
R1
13.89
R2
14.07
R3
14.33

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
12.0862 14.4938
±9.06% from 13.29, made 2026-09-05 · resolves 2026-09-12
SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22034 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 3 neutral · 1 sell
Moving averagesNEUTRAL
6 buy · 0 neutral · 6 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)54.20NEUTRAL
Stochastic %K (14)76.77NEUTRAL
CCI (20)113.75SELL
Williams %R (14)-23.23NEUTRAL
MACD (12,26,9)0.14BUY
ROC (10)3.55BUY
Momentum (10)0.47BUY
EMA (10)13.41BUY
SMA (10)13.21BUY
EMA (20)13.41BUY
SMA (20)13.23BUY
EMA (30)13.53BUY
SMA (30)13.51BUY
EMA (50)13.84SELL
SMA (50)13.90SELL
EMA (100)14.59SELL
SMA (100)14.70SELL
EMA (200)15.86SELL
SMA (200)16.17SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About MediWound Ltd.

Healthcare · Biotechnology

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

mediwound.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

TimeframeBiasBars
📅 Daily BULLISH 43
⏰ 4H NEUTRAL 23
🕐 1H BULLISH 95
⏱ 15-Min RANGING 130
⏲ 5-Min BULLISH 234

Momentum & Volume

-0.15
MACD (no fresh cross)

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NEUTRAL   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.